Arabic Arabic English English French French German German
dark

Talis Biomedical Announces CEO Transition Kim Popovits to serve as interim CEO

Talis Biomedical Corporation today announced that effective immediately Brian Coe has stepped down as President, CEO and Director and will continue to work with the company as an advisor. The company also announced that Kim Popovits has been appointed as interim CEO Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How Pharma Startups Can Remain Competitive in Today’s Market

Next Post

Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)

Related Posts
Total
0
Share